Van der Boechorststraat 7
Afdeling MMI Kamer B-340
1081 BT Amsterdam
The Netherlands
T +31 20 444 8307
Nederlands English

About us

Microbiome is leading in the field of innovative molecular microbiological diagnostics. read more >


Finding innovative solutions to medical problems drives us. read more >


Use of the site of Microbiome is subject to the conditions and restrictions mentioned below. Access to and the use of this site mean that the user agrees with mentioned below. Any liability for any damages resulting from access to and use of the site is by Microbiome expressly rejected. There is no guarantee for the flawless and uninterrupted functioning of the site. There absolutely no guarantee or declaration, nor explicitly nor tacitly, becomes given to the point of correctness or completeness of the information which on the site it is published or to what by means of the site access it is provided. Microbiome accept absolutely no liability for the information and if recommendations which are published on the site or to which is ordered by means of the site access. This information and recommendations can be modified moreover without preceding warning.

All data represented on the site, including texts, photographs, illustrations, graphic material, (trade) names, logo' s, products and service marks are in property or permit at Microbiome and are protected copyright, trademark and/or some other intellectual tenure. (Intellectual) tenures go up in an absolutely no manner (Right) persons who obtain to the site. The content of this site may only be used for non-commercial and/or private purposes. The user of the site are prohibited from the site to reproduce, modify, delete, forward, distribute, disseminate or reward available to third parties without explicit, written, authorisation of Microbiome References or hyperlinks to other sites not owned by one of the institutions are only included for the information of the user of the site. Microbiome gives no warranty nor accepts any liability for the content of such sites

Latest news

As Tuberculosis Grows More Difficult to Control, Vaccine Candidate to Prevent Disease Enters Clinical Testing

Aeras and the Infectious Disease Research Institute (IDRI) announce today the start of the first clinical trial of IDRI's novel tuberculosis vaccine candidate,... read more >

Growing Resistance to Gonorrhea Treatment

Recent research explains why treating gonorrhea has grown more difficult. Scientists from Harvard University, the Centers for Disease Control and Prevention... read more >

Partners of Microbiome

We develop integrated solutions together with leading manufacturers from the diagnostics and pharmaceutical industries, helping them to leverage our leading sample & assay technologies as part of their own offerings. read more >